A Metabolism-Driven Prognostic Model and PSMD14–SP1–GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma
Journal of Investigative Dermatology · 2026
DOI: 10.1016/j.jid.2025.08.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026. Verfasst von Jiaheng Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Department of Plastic Surgery, Xiangya Ho…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital.
Abstract (Originalsprache)
Melanoma is a highly aggressive cutaneous malignancy characterized by a strong propensity for metastasis and therapy resistance, with its progression being closely linked to metabolic reprogramming. This study integrated multiomics data (The Cancer Genome Atlas, Gene Expression Omnibus, European Nucleotide Archive) and advanced machine learning to develop prognostic and immunotherapy prediction models for melanoma, focusing on 114 metabolism-related pathways. Cox regression identified 70 genes linked to survival, with functional enrichment revealing key metabolic pathway alterations. A metabolism-related prognostic model (MRPM) was constructed using 101 combinations of machine learning algorithms, demonstrating superior predictive accuracy across 4 cohorts. High-risk patients showed worse survival and immunotherapy response in melanoma and other cancers. Tumor microenvironment analysis revealed MRPM's negative correlation with immune infiltration and positive association with tumor purity. Single-cell sequencing highlighted MRPM gene enrichment in melanocytes. Mechanistically, GYS1 (the key gene in MRPM) emerged as a pivotal prognostic gene that promotes melanoma proliferation and metastasis. Regulatory studies uncovered SP1's transcriptional control of GYS1- and PSMD14-mediated stabilization of SP1 through K48-linked ubiquitination removal. In vivo validation confirmed that PSMD14 knockdown suppressed tumor growth through SP1-GYS1 axis disruption. This work establishes MRPM as a robust predictive tool and elucidates the PSMD14-SP1-GYS1 regulatory network as a potential therapeutic target in melanoma metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Department of Plastic Surgery, Xiangya Hospital, Central South University, Changsha, China; Department of Plast…
- Department of Plastic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
- Department of Burn and Plastic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Lung Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Förderung
- Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital
Zitieren
APA
Xie, J., Zhao, S., Wu, D., Ma, C., Yan, W., Zhang, P., Lu, Q., Wan, Z., Tang, Q., Li, L., Wang, M., & He, Y. (2026). A Metabolism-Driven Prognostic Model and PSMD14–SP1–GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2025.08.044
Vancouver
Xie J, Zhao S, Wu D, Ma C, Yan W, Zhang P, et al. A Metabolism-Driven Prognostic Model and PSMD14–SP1–GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma. Journal of Investigative Dermatology. 2026. doi:10.1016/j.jid.2025.08.044
BibTeX
@article{Xie2026,
author = {Xie, Jiaheng and Zhao, Songyun and Wu, Dan and Ma, Chenfeng and Yan, Wei and Zhang, Pengpeng and Lu, Qingyu and Wan, Zeyu and Tang, Qikai and Li, Liqun and Wang, Ming and He, Yucang},
title = {A Metabolism-Driven Prognostic Model and PSMD14–SP1–GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma},
journal = {Journal of Investigative Dermatology},
year = {2026},
doi = {10.1016/j.jid.2025.08.044}
}
EUVIMED